Noncompliance to Apixaban for A-Fib Due to Many Factors
Improved communication with patients about cost, bleeding, and monitoring may increase compliance
Thromboembolic Disorders
Extended Anticoagulation Tied to Major Bleeding Risk
Long-term risks and consequences are considerable for patients receiving VKA, DOAC after first unprovoked VTE
Mycophenolate Mofetil Treats Immune Thrombocytopenia
Fewer treatment failures and greater response, but poorer quality of life seen when added to a glucocorticoid for first-line treatment
FDA: New Warnings and Limitations Set for Certain JAK Inhibitors
The revisions are based on a completed review of a large randomized safety clinical trial, which included 4362 patients with rheumatoid arthritis.
Vagus Nerve Stimulation System Approved for Post Stroke Rehabilitation Therapy
The Vivistim System features an implantable pulse generator, which is placed just under the skin in the chest of the patient, and a lead wire.
Vazalore Liquid-Filled Aspirin Capsules Now Available Over the Counter
Vazalore™, a liquid-filled aspirin capsule, has been made available by PLx Pharma. Vazalore was approved by the Food and Drug Administration in March 2021. It is indicated for patients with vascular disease and those with rheumatologic diseases who are candidates for aspirin therapy. The product is designed to improve the absorption of aspirin by targeting…
Xarelto Approval Expands to Symptomatic PAD After Revascularization
The approval was based on data from the phase 3 VOYAGER PAD study.
Features of Vaccine-Induced Thrombotic Syndrome Studied
No individual risk factors identified for VITT, but increased mortality seen for those with cerebral venous sinus thrombosis, low platelets
Large PICC Size May Up Risk for Thrombosis in Cancer Patients
Risk for thrombosis doubled if catheter-to-vein ratio exceeds 45 percent for peripherally inserted central catheter
Midodrine Cuts Recurrent Syncope in Young, Healthy Patients
Absolute risk reduced by 19 percentage points, with number needed to treat to prevent syncope of 5.3
